King Rachel K.
SEC CIK 1589712 · EDGAR
BoughtSold
Most active insiders at NVAX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Draghia-Akli Ruxandra | Section 16 | — | — |
| 2 | O'Hara Elaine | EVP, Chief Strategy Off | — | — |
| 3 | Shiver John W. | Dir | — | — |
| 4 | Newton Charles W. | Dir | — | — |
| 5 | Jacobs John C | Pres, CEO, Dir | — | — |
| 6 | King Rachel K. | Dir | — | — |
| 7 | Kelly James Patrick | EVP, CFO, Treas | — | — |
| 8 | Casey Mark J | EVP, CLO | — | — |
| 9 | Alton Gregg H | Dir | — | — |
| 10 | Rodgers Richard J | Dir | — | — |
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-23 19:57 | 2026-06-20 | NVAX | NOVAVAX INC | King Rachel K. | Dir | M - OptEx | — | +18.9K | 44.1K | +75% | — |
| D | 2025-06-13 | 2025-06-12 | NVAX | NOVAVAX INC | King Rachel K. | Dir | M - OptEx | $0.00 | +10.4K | 25.2K | +71% | $0 |
| 2025-01-02 | 2024-12-13 | NVAX | NOVAVAX INC | King Rachel K. | Dir | S - Sale | $9.02 | -4,150 | 14.8K | -22% | -$37.4K | |
| D | 2024-06-14 | 2024-06-12 | NVAX | NOVAVAX INC | King Rachel K. | Dir | M - OptEx | $0.00 | +6,670 | 18.9K | +54% | $0 |
| 2024-04-02 | 2024-03-29 | CBIO | CRESCENT BIOPHARMA, INC. | King Rachel K. | Dir | A - Grant | $3.00 | +3,334 | 515.2K | +0.7% | +$10.0K | |
| 2024-01-02 | 2023-12-29 | CBIO | CRESCENT BIOPHARMA, INC. | King Rachel K. | Dir | A - Grant | $2.36 | +4,238 | 511.9K | +0.8% | +$10.0K | |
| 2023-10-03 | 2023-09-30 | CBIO | CRESCENT BIOPHARMA, INC. | King Rachel K. | Dir | A - Grant | $1.50 | +6,667 | 507.6K | +1% | +$10.0K | |
| D | 2023-06-13 | 2023-06-10 | NVAX | NOVAVAX INC | King Rachel K. | Dir | M - OptEx | — | +3,100 | 10.1K | +45% | — |
| D | 2022-06-21 | 2022-06-17 | NVAX | NOVAVAX INC | King Rachel K. | Dir | M - OptEx | — | +700 | 6,950 | +11% | — |
| DA | 2021-08-20 | 2021-06-25 | NVAX | NOVAVAX INC | King Rachel K. | Dir | M - OptEx | — | +3,450 | 6,250 | +123% | — |
Purchase Sale Sale after option exercise All abbreviations